GlaxoSmithKline | GSK - Interest Income

Stock Price
2,162.50
Daily Change
-17.50 -0.80%
Monthly
13.73%
Yearly
49.86%
Q1 Forecast
1,839.16

GlaxoSmithKline reported GBP26M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
argenx SE USD 38.4M 1.28M Jun/2025
AstraZeneca USD 68M 16M Jun/2025
Bayer EUR 130M 38M Sep/2025
Biogen USD 32.3M 8.4M Jun/2025
Eli Lilly USD 65M 25M Sep/2025
Fresenius Medical Care EUR 21.85M 6.87M Jun/2025
Galapagos EUR 12.56M 4.66M Mar/2025
Genmab DKK 25M 8M Jun/2025
Gilead Sciences USD 73M 21M Jun/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Glaxosmithkline GBP 26M 24M Sep/2025
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Merck EUR 17M 11M Jun/2025
Merck USD 96M 27M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Philips EUR 23M 10M Jun/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 114M 38M Sep/2025
Smith & Nephew USD 15M 6M Dec/2024